NCT02754167 - Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 6, 2016

Primary Completion Date

February 6, 2017

Study Completion Date

December 31, 2017

Conditions

Anemia of Chronic Kidney Disease

Interventions

BIOLOGICAL

PRS-080#022-DP

Hepcidin antagonism to mobilize iron and to treat anemia

BIOLOGICAL

PRS-080-Placebo#001

Placebo comparator

Trial Locations (2)

St. Joseph Krankenhaus, Berlin

Technical University, Medical Department, Munich